These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


654 related items for PubMed ID: 16650159

  • 1. Borderline systemic lupus erythematosus (SLE): a separate entity or a forerunner to SLE?
    Al Attia HM.
    Int J Dermatol; 2006 Apr; 45(4):366-9. PubMed ID: 16650159
    [Abstract] [Full Text] [Related]

  • 2. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

  • 3. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
    To CH, Petri M.
    Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
    [Abstract] [Full Text] [Related]

  • 4. [Systemic lupus erythematosus in Lomé, Togo].
    Kombate K, Saka B, Oniankitan OI, Sodonougbo P, Mouhari-Toure A, Tchangai-Walla K, Pitche P.
    Med Trop (Mars); 2008 Jun; 68(3):283-6. PubMed ID: 18689322
    [Abstract] [Full Text] [Related]

  • 5. Clinical and immunological manifestations of systemic lupus erythematosus: study on 146 south Tunisian patients.
    Jallouli M, Frigui M, Hmida MB, Marzouk S, Kaddour N, Bahloul Z.
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):1001-8. PubMed ID: 18974596
    [Abstract] [Full Text] [Related]

  • 6. [Hematological abnormalities in systemic lupus erythematosus and clinical significance thereof: comparative analysis of 236 cases].
    Chen JL, Huang XM, Zeng XJ, Wang Y, Zhou MX, Ma YH, Li RS, Shen T.
    Zhonghua Yi Xue Za Zhi; 2007 May 22; 87(19):1330-3. PubMed ID: 17727778
    [Abstract] [Full Text] [Related]

  • 7. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Bardin N, Desplat-Jego S, Daniel L, Jourde Chiche N, Sanmarco M.
    Autoimmunity; 2009 Jan 22; 42(1):63-8. PubMed ID: 19127456
    [Abstract] [Full Text] [Related]

  • 8. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations.
    Vilá LM, Alarcón GS, McGwin G, Friedman AW, Baethge BA, Bastian HM, Fessler BJ, Reveille JD, LUMINA Study Group.
    Rheumatology (Oxford); 2004 Mar 22; 43(3):358-63. PubMed ID: 14623949
    [Abstract] [Full Text] [Related]

  • 9. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.
    Arthritis Res Ther; 2006 Mar 22; 8(6):R162. PubMed ID: 17062137
    [Abstract] [Full Text] [Related]

  • 10. Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies.
    Ignat GP, Rat AC, Sychra JJ, Vo J, Varga J, Teodorescu M.
    J Rheumatol; 2003 Aug 22; 30(8):1761-9. PubMed ID: 12913932
    [Abstract] [Full Text] [Related]

  • 11. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007 Aug 22; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 12. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D, Williams DG, Taube D, Vilches AR, Turner DR, Cameron JS, Ogg CS.
    Q J Med; 1983 Aug 22; 52(208):471-87. PubMed ID: 6606818
    [Abstract] [Full Text] [Related]

  • 13. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A, Szodoray P, Kiss E, Kapitany A, Szegedi G, Zeher M.
    Hum Immunol; 2006 Nov 22; 67(11):924-30. PubMed ID: 17145372
    [Abstract] [Full Text] [Related]

  • 14. Systemic lupus erythematosus in the Fars Province of Iran.
    Nazarinia MA, Ghaffarpasand F, Shamsdin A, Karimi AA, Abbasi N, Amiri A.
    Lupus; 2008 Mar 22; 17(3):221-7. PubMed ID: 18372364
    [Abstract] [Full Text] [Related]

  • 15. [Is the primary antiphospholipid syndrome a forerunner of SLE?].
    Tarr T, Muzes G, Pitlik E, Lakos G, Csépány T, Soltész P, Zeher M, Szegedi G, Kiss E.
    Orv Hetil; 2005 Jan 30; 146(5):203-7. PubMed ID: 15773587
    [Abstract] [Full Text] [Related]

  • 16. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
    Ng KP, Manson JJ, Rahman A, Isenberg DA.
    Arthritis Rheum; 2006 Dec 15; 55(6):900-4. PubMed ID: 17139667
    [Abstract] [Full Text] [Related]

  • 17. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE, Lauwerys BR, De Keyser F, Huizinga TW, Isenberg D, Cebecauer L, Dehoorne J, Joos R, Hendrickx G, Houssiau F, Elewaut D.
    Ann Rheum Dis; 2009 Mar 15; 68(3):412-5. PubMed ID: 18930995
    [Abstract] [Full Text] [Related]

  • 18. [Clinico-biological classification of systemic lupus].
    Meyer O.
    Ann Med Interne (Paris); 1990 Mar 15; 141(3):229-33. PubMed ID: 2369011
    [Abstract] [Full Text] [Related]

  • 19. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus.
    Jacobi AM, Odendahl M, Reiter K, Bruns A, Burmester GR, Radbruch A, Valet G, Lipsky PE, Dörner T.
    Arthritis Rheum; 2003 May 15; 48(5):1332-42. PubMed ID: 12746906
    [Abstract] [Full Text] [Related]

  • 20. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia.
    Al Arfaj AS, Khalil N.
    Lupus; 2009 Apr 15; 18(5):465-73. PubMed ID: 19318403
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.